NURR1 Alterations in Perinatal Stress: A First Step towards Late-Onset Diseases? A Narrative Review
- PMID: 33302583
- PMCID: PMC7764589
- DOI: 10.3390/biomedicines8120584
NURR1 Alterations in Perinatal Stress: A First Step towards Late-Onset Diseases? A Narrative Review
Abstract
Perinatal life represents a delicate phase of development where stimuli of all sorts, coming to or from the mother, can influence the programming of the future baby's health. These stimuli may have consequences that persist throughout adulthood. Nuclear receptor related 1 protein (NURR1), a transcription factor with a critical role in the development of the dopaminergic neurons in the midbrain, mediates the response to stressful environmental stimuli in the perinatal period. During pregnancy, low-grade inflammation triggered by maternal obesity, hyperinsulinemia or vaginal infections alters NURR1 expression in human gestational tissues. A similar scenario is triggered by exposure to neurotoxic compounds, which are associated with NURR1 epigenetic deregulation in the offspring, with potential intergenerational effects. Since these alterations have been associated with an increased risk of developing late-onset diseases in children, NURR1, alone, or in combination with other molecular markers, has been proposed as a new prognostic tool and a potential therapeutic target for several pathological conditions. This narrative review describes perinatal stress associated with NURR1 gene deregulation, which is proposed here as a mediator of late-onset consequences of early life events.
Keywords: NURR1; early life; inflammation; late-onset diseases; perinatal stress.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Mechanisms of NURR1 Regulation: Consequences for Its Biological Activity and Involvement in Pathology.Int J Mol Sci. 2023 Jul 31;24(15):12280. doi: 10.3390/ijms241512280. Int J Mol Sci. 2023. PMID: 37569656 Free PMC article. Review.
-
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.Int J Mol Sci. 2022 Dec 19;23(24):16184. doi: 10.3390/ijms232416184. Int J Mol Sci. 2022. PMID: 36555826 Free PMC article. Review.
-
Nurr1 expression is modified by inflammation in microglia.Neuroreport. 2016 Oct 19;27(15):1120-7. doi: 10.1097/WNR.0000000000000665. Neuroreport. 2016. PMID: 27532877 Free PMC article.
-
The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival.Int Rev Neurobiol. 2012;102:1-22. doi: 10.1016/B978-0-12-386986-9.00001-6. Int Rev Neurobiol. 2012. PMID: 22748824 Review.
-
Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons.Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4013-8. doi: 10.1073/pnas.95.7.4013. Proc Natl Acad Sci U S A. 1998. PMID: 9520484 Free PMC article.
Cited by
-
A Scoping Review of Life-Course Psychosocial Stress and Kidney Function.Children (Basel). 2021 Sep 16;8(9):810. doi: 10.3390/children8090810. Children (Basel). 2021. PMID: 34572242 Free PMC article.
-
Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study.Int J Mol Sci. 2025 Jun 7;26(12):5468. doi: 10.3390/ijms26125468. Int J Mol Sci. 2025. PMID: 40564942 Free PMC article.
-
Biomarkers in Neurodegenerative Diseases.Biomedicines. 2022 Jan 20;10(2):215. doi: 10.3390/biomedicines10020215. Biomedicines. 2022. PMID: 35203425 Free PMC article.
-
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.Sci Rep. 2021 Oct 19;11(1):20670. doi: 10.1038/s41598-021-00192-y. Sci Rep. 2021. PMID: 34667209 Free PMC article.
References
-
- Carroll J.C., Iba M., Bangasser D.A., Valentino R.J., James M.J., Brunden K.R., Lee V.M.-Y., Trojanowski J.Q. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J. Neurosci. 2011;31:14436–14449. doi: 10.1523/JNEUROSCI.3836-11.2011. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources